These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25220271)

  • 61. Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.
    Sahin OZ; Gurses S; Taslı F; Yavas H; Ersoy R; Uzum A; Cirit M
    Ren Fail; 2013; 35(2):222-5. PubMed ID: 23176021
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
    Chan RW; Lai FM; Li EK; Tam LS; Wong TY; Szeto CY; Li PK; Szeto CC
    Arthritis Rheum; 2004 Sep; 50(9):2882-90. PubMed ID: 15457456
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
    Gunnarsson I; Sundelin B; Heimbürger M; Forslid J; van Vollenhoven R; Lundberg I; Jacobson SH
    J Rheumatol; 2002 Apr; 29(4):693-9. PubMed ID: 11950009
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Renal cell apoptosis in human lupus nephritis: a histological study.
    Faurschou M; Penkowa M; Andersen CB; Starklint H; Jacobsen S
    Lupus; 2009 Oct; 18(11):994-9. PubMed ID: 19762401
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
    Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare.
    Singh RG; Usha ; Rathore SS; Behura SK; Singh NK
    Lupus; 2012 Oct; 21(11):1214-8. PubMed ID: 22759858
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Renal alpha-smooth muscle actin: a new prognostic factor for lupus nephritis.
    Makni K; Jarraya F; Khabir A; Hentati B; Hmida MB; Makni H; Boudawara T; Jlidi R; Hachicha J; Ayadi H
    Nephrology (Carlton); 2009 Aug; 14(5):499-505. PubMed ID: 19674318
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Urinary T cells in active lupus nephritis show an effector memory phenotype.
    Dolff S; Abdulahad WH; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
    Ann Rheum Dis; 2010 Nov; 69(11):2034-41. PubMed ID: 20472588
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serial renal biopsy in systemic lupus erythematosus.
    Bajaj S; Albert L; Gladman DD; Urowitz MB; Hallett DC; Ritchie S
    J Rheumatol; 2000 Dec; 27(12):2822-6. PubMed ID: 11128670
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.
    Stoenoiu MS; Aydin S; Tektonidou M; Ravelingien I; le Guern V; Fiehn C; Remy P; Delahousse M; Petera P; Quémeneur T; Vasconcelos C; D'Cruz D; Gilboe IM; Jadoul M; Karras A; Depresseux G; Guillevin L; Cervera R; Cosyns JP; Houssiau FA;
    Nephrol Dial Transplant; 2012 May; 27(5):1924-30. PubMed ID: 22110048
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of the kidney biopsy in the treatment of lupus nephritis.
    Kashgarian M
    Ren Fail; 1996 Sep; 18(5):765-73. PubMed ID: 8903091
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Semi-quantitative evaluation of gallium-67 scintigraphy in lupus nephritis.
    Lin WY; Hsieh JF; Tsai SC; Lan JL; Cheng KY; Wang SJ
    Eur J Nucl Med; 2000 Nov; 27(11):1626-31. PubMed ID: 11105818
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunopathology of lupus nephritis.
    Anders HJ; Fogo AB
    Semin Immunopathol; 2014 Jul; 36(4):443-59. PubMed ID: 24402709
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications.
    Seshan SV; Jennette JC
    Arch Pathol Lab Med; 2009 Feb; 133(2):233-48. PubMed ID: 19195967
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Management of Lupus Nephritis: An Update.
    Gupta KL; Bharati J
    J Assoc Physicians India; 2022 Mar; 70(3):11-12. PubMed ID: 35438287
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A clinico-pathological study of lupus nephritis based on the International Society of Nephrology-Renal Pathology Society 2003 classification system.
    Satish S; Deka P; Shetty MS
    J Lab Physicians; 2017; 9(3):149-155. PubMed ID: 28706383
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Urinary sediment suggests lupus nephritis histology.
    Martínez-Martínez MU; Llamazares-Azuara LM; Martínez-Galla D; Mandeville PB; Valadez-Castillo F; Román-Acosta S; Borjas-García JA; Abud-Mendoza C
    Lupus; 2017 May; 26(6):580-587. PubMed ID: 27687029
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Value of gallium-67 scintigraphy in monitoring the renal activity in lupus nephritis.
    Lin WY; Lan JL; Cheng KY; Wang SJ
    Scand J Rheumatol; 1998; 27(1):42-5. PubMed ID: 9506877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.